Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
GSS Announcements
GSS responds to the BCAL Diagnostics…
GSS
GENETIC SIGNATURES LIMITED
Market sensitive
GSS responds to the BCAL Diagnostics Announcement
Date and time
3 July 2026 at 12:41 am
Announcement type
Company Administration
Show details
Hide details
Category
Other
Report codes
12008
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
GSS announcement history
Recent GSS announcements
Commercial Testing Commences at Hvidovre Hospital in Denmark
Quarterly Activities/Appendix 4C Cash Flow Report
Becoming a substantial holder from BDX
BDX: BCAL to Acquire Shares in Genetic Signatures
Ceasing to be a substantial holder
Change of Company Secretary